Novartis has announced internal structural changes that it says will “focus” its pharmaceuticals division by creating two business units, Novartis …
Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEO
Tridem begins phase Ib trial of Parkinson’s disease vaccine

